PRGO
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2022-01-01–present
Board Member
Syntec Optics Holdings, Inc. (OPTX)Board Member
PERRIGO Co plc (PRGO)Equibles does not estimate personal net worth.
Get an email with a short summary when PERRIGO Co plc publishes a filing, an earnings call transcript or a press release.
Get PRGO alertsAlbert A. Manzone is recorded as CEO at PERRIGO Co plc (PRGO) since June 7, 2026, Board Member at PERRIGO Co plc (PRGO) since January 1, 2022 and Board Member at Syntec Optics Holdings, Inc. (OPTX) since January 1, 2023. The newest filing on record that lists Albert A. Manzone as Board Member at PERRIGO Co plc (PRGO) is dated March 20, 2026. The newest filing on record that lists Albert A. Manzone as Board Member at Syntec Optics Holdings, Inc. (OPTX) is dated December 8, 2025. PERRIGO Co plc reported in an 8-K filed June 8, 2026 that Albert A. Manzone was appointed Interim President and Chief Executive Officer, effective June 7, 2026. PERRIGO Co plc reported in an 8-K filed July 14, 2022 that Albert A. Manzone was appointed member of the Company's board of directors, effective July 30, 2022. Albert A. Manzone has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for PERRIGO Co plc on November 4, 2026. PERRIGO Co plc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Syntec Optics Holdings, Inc. is classified in the Electronic Components industry within the Technology sector. Other leadership on record at PERRIGO Co plc includes Patrick Lockwood-Taylor (CEO), Eduardo Bezerra (CFO), Charles Atkinson (General Counsel) and 7 others.
“On June 7, 2026, the Board appointed Albert A. Manzone, Director and member of the Audit Committee of the Board, as the Company's Interim President and Chief Executive Officer.”
“On July 11, 2022, the Board of Directors of Perrigo Company plc (the "Company" or "Perrigo") appointed Albert A. Manzone to serve as a member of the Company's board of directors (the "Board"), to be effective July 30, 2022.”
“Over my first five months at Perigo, I have spent a significant amount of time listening to our customers, our consumers, and our people, digging into the business and our capabilities, and developing a deeper understanding of what we do well and where we can be better.”
“Thank you, Susan, for having us, and thank you all for attending today Perigo presentations. So I'm going to take you through a quick presentation and then happy to take any questions that you may have.”
2026-06-07–present
2023-01-01–present
Last confirmed December 8, 2025
2022-01-01–present
Last confirmed March 20, 2026
PRGO
Drug Manufacturers - Specialty & Generic · Healthcare
CEO, Board Member
2022-01-01–present
Electronic Components · Technology
Board Member
2023-01-01–present